4.6 Review

The Shigella Type III Secretion System: An Overview from Top to Bottom

Journal

MICROORGANISMS
Volume 9, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/microorganisms9020451

Keywords

Shigella; type III secretion system; T3SS; injectisome; tip complex; translocator; sorting platform

Categories

Funding

  1. National Institute of Allergies and Infectious Disease awards NIAID [R01 AI123351, R21 AI146517]

Ask authors/readers for more resources

Shigella, a human-restricted pathogen causing bacillary dysentery, primarily relies on a type III secretion system (T3SS) consisting of multiple components and proteins for its virulence. Studying the T3SS injectisome in Shigella and related systems helps to understand its pathogenic mechanisms and develop prevention strategies.
Shigella comprises four species of human-restricted pathogens causing bacillary dysentery. While Shigella possesses multiple genetic loci contributing to virulence, a type III secretion system (T3SS) is its primary virulence factor. The Shigella T3SS nanomachine consists of four major assemblies: the cytoplasmic sorting platform; the envelope-spanning core/basal body; an exposed needle; and a needle-associated tip complex with associated translocon that is inserted into host cell membranes. The initial subversion of host cell activities is carried out by the effector functions of the invasion plasmid antigen (Ipa) translocator proteins, with the cell ultimately being controlled by dedicated effector proteins that are injected into the host cytoplasm though the translocon. Much of the information now available on the T3SS injectisome has been accumulated through collective studies on the T3SS from three systems, those of Shigella flexneri, Salmonella typhimurium and Yersinia enterocolitica/Yersinia pestis. In this review, we will touch upon the important features of the T3SS injectisome that have come to light because of research in the Shigella and closely related systems. We will also briefly highlight some of the strategies being considered to target the Shigella T3SS for disease prevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available